Top

Molecular Neurodegeneration

Published in:

Open Access 01-12-2011 | Research article

Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states

Authors: Mercedes Prudencio, David R Borchelt

Published in: Molecular Neurodegeneration | Issue 1/2011

Abstract

Background

Mutations in superoxide dismutase 1 (SOD1), which are one cause of familial amyotrophic lateral sclerosis (fALS), induce misfolding and aggregation of the protein. Misfolding can be detected by the binding of antibodies raised against peptide epitopes that are normally buried in the native conformation, shifts in solubility in non-ionic detergents, and the formation of macromolecular inclusions. In the present study, we investigate the relationship between detergent-insoluble and sedimentable forms of mutant SOD1, forms of mutant SOD1 with aberrantly accessible epitopes, and mutant protein in inclusions with the goal of defining the spectrum of misfolded states that mutant SOD1 can adopt.

Results

Using combined approaches in cultured cell models, we demonstrate that a substantial fraction of mutant SOD1 adopts a non-native conformation that remains soluble and freely mobile. We also show that mutant SOD1 can produce multimeric assemblies of which some are insoluble in detergent and large enough to sediment by ultracentrifugation and some are large enough to detect visually. Three conformationally restricted antibodies were found to be useful in discriminating mal-folded forms of mutant SOD1. An antibody termed C4F6 displays properties consistent with recognition of soluble, freely mobile, mal-folded mutant SOD1. An antibody termed SEDI, which recognizes C-terminal residues, detects larger inclusion structures as well as soluble misfolded entities. An antibody termed hSOD1, which recognizes aa 24-36, detects an epitope shared by soluble non-natively folded WT and mutant SOD1. This epitope becomes inaccessible in aggregates of mutant SOD1.

Conclusions

Our studies demonstrate how different methods of detecting misfolding and aggregation of mutant SOD1 reveal different forms of aberrantly folded protein. Immunological and biochemical methods can be used in combination to detect soluble and insoluble misfolded forms of mutant SOD1. Our findings support the view that mutant SOD1 can adopt multiple misfolded conformations with the potential that different structural variants mediate different aspects of fALS.

Available only for authorised users

Prudencio M, Hart PJ, Borchelt DR, Andersen PM: Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet. 2009, 18: 3217-3226. 10.1093/hmg/ddp260.PubMedPubMedCentralCrossRef

Shibata N, Hirano A, Kobayashi M, Siddique T, Deng H-X, Hung W-Y, Kato T, Asayama K: Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol. 1996, 55: 481-490. 10.1097/00005072-199604000-00011.PubMedCrossRef

Kato S, Shimoda M, Watanabe Y, Nakashima K, Takahashi K, Ohama E: Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1 gene: multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes. J Neuropathol Exp Neurol. 1996, 55: 1089-1101.PubMedCrossRef

Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, et al: ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997, 18: 327-338. 10.1016/S0896-6273(00)80272-X.PubMedCrossRef

Bruijn LI, Houseweart MK, Kato S, Anderson KL, Anderson SD, Ohama E, Reaume AG, Scott RW, Cleveland DW: Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998, 281: 1851-1854.PubMedCrossRef

Kato S, Horiuchi S, Liu J, Cleveland DW, Shibata N, Nakashima K, Nagai R, Hirano A, Takikawa M, Kato M, et al: Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with a G85R mutation. Acta Neuropathol. 2000, 100: 490-505. 10.1007/s004010000226.PubMedCrossRef

Stieber A, Gonatas JO, Gonatas NK: Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis. J Neurol Sci. 2000, 177: 114-123. 10.1016/S0022-510X(00)00351-8.PubMedCrossRef

Stieber A, Gonatas JO, Gonatas NK: Aggregation of ubiquitin and a mutant ALS-linked SOD1 protein correlate with disease progression and fragmentation of the Golgi apparatus. J Neurol Sci. 2000, 173: 53-62. 10.1016/S0022-510X(99)00300-7.PubMedCrossRef

Kato S, Sumi-Akamaru H, Fujimura H, Sakoda S, Kato M, Hirano A, Takikawa M, Ohama E: Copper chaperone for superoxide dismutase co-aggregates with superoxide dismutase 1 (SOD1) in neuronal Lewy body-like hyaline inclusions: an immunohistochemical study on familial amyotrophic lateral sclerosis with SOD1 gene mutation. Acta Neuropathol. 2001, 102: 233-238.PubMed

10.

Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD: Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues. Neurobiol Dis. 2001, 8: 933-941. 10.1006/nbdi.2001.0443.PubMedCrossRef

11.

Ohi T, Saita K, Takechi S, Nabesima K, Tashiro H, Shiomi K, Sugimoto S, Akematsu T, Nakayama T, Iwaki T, et al: Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with a His46Arg mutation in Cu/Zn superoxide dismutase. J Neurol Sci. 2002, 197: 73-78. 10.1016/S0022-510X(02)00054-0.PubMedCrossRef

12.

Arisato T, Okubo R, Arata H, Abe K, Fukada K, Sakoda S, Shimizu A, Qin XH, Izumo S, Osame M, et al: Clinical and pathological studies of familial amyotrophic lateral sclerosis (FALS) with SOD1 H46R mutation in large Japanese families. Acta Neuropathol. 2003, 106: 561-568. 10.1007/s00401-003-0763-5.PubMedCrossRef

13.

Sasaki S, Warita H, Murakami T, Shibata N, Komori T, Abe K, Kobayashi M, Iwata M: Ultrastructural study of aggregates in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2005, 109: 247-255. 10.1007/s00401-004-0939-7.PubMedCrossRef

14.

Sasaki S, Nagai M, Aoki M, Komori T, Itoyama Y, Iwata M: Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene. J Neuropathol Exp Neurol. 2007, 66: 517-524. 10.1097/01.jnen.0000263868.84188.3b.PubMedCrossRef

15.

Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL: An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995, 14: 1105-1116. 10.1016/0896-6273(95)90259-7.PubMedCrossRef

16.

Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, Jenkins NA, Borchelt DR: Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet. 2003, 12: 2753-2764. 10.1093/hmg/ddg312.PubMedCrossRef

17.

Rakhit R, Robertson J, Vande VC, Horne P, Ruth DM, Griffin J, Cleveland DW, Cashman NR, Chakrabartty A: An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat Med. 2007, 13: 754-759. 10.1038/nm1559.PubMedCrossRef

18.

Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, Gredal O, Nilsson P, Marklund SL: Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004, 127: 73-88. 10.1093/brain/awh005.PubMedCrossRef

19.

Basso M, Massignan T, Samengo G, Cheroni C, De Biasi S, Salmona M, Bendotti C, Bonetto V: Insoluble mutant SOD1 is partly oligoubiquitinated in amyotrophic lateral sclerosis mice. J Biol Chem. 2006, 281: 33325-33335. 10.1074/jbc.M603489200.PubMedCrossRef

20.

Karch CM, Borchelt DR: A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem. 2008, 283: 13528-13537. 10.1074/jbc.M800564200.PubMedPubMedCentralCrossRef

21.

Prudencio M, Durazo A, Whitelegge JP, Borchelt DR: Modulation of mutant superoxide dismutase 1 aggregation by co-expression of wild-type enzyme. J Neurochem. 2009, 108: 1009-1018. 10.1111/j.1471-4159.2008.05839.x.PubMedPubMedCentralCrossRef

22.

Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR: Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA. 2009, 106: 7774-7779. 10.1073/pnas.0902505106.PubMedPubMedCentralCrossRef

23.

Boylan K, Yang C, Crook J, Overstreet K, Heckman M, Wang Y, Borchelt D, Shaw G: Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem. 2009, 111: 1182-1191. 10.1111/j.1471-4159.2009.06386.x.PubMedCrossRef

24.

Ezzi SA, Urushitani M, Julien JP: Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007, 102: 170-178. 10.1111/j.1471-4159.2007.04531.x.PubMedCrossRef

25.

Gros-Louis F, Soucy G, Lariviere R, Julien JP: Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem. 2010, 113: 1188-1199.PubMed

26.

Karch CM, Borchelt DR: An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis. J Neurochem. 2010, 113: 1092-1100.PubMedPubMedCentral

27.

Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, et al: Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010, 13: 1396-1403. 10.1038/nn.2660.PubMedPubMedCentralCrossRef

28.

Corcoran LJ, Mitchison TJ, Liu Q: A novel action of histone deacetylase inhibitors in a protein aggresome disease model. Curr Biol. 2004, 14: 488-492. 10.1016/j.cub.2004.03.003.PubMedCrossRef

29.

Zhang F, Zhu H: Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Biochim Biophys Acta. 2006, 1760: 404-414. 10.1016/j.bbagen.2005.11.024.PubMedCrossRef

30.

Fei E, Jia N, Yan M, Ying Z, Sun Q, Wang H, Zhang T, Ma X, Ding H, Yao X, et al: SUMO-1 modification increases human SOD1 stability and aggregation. Biochem Biophys Res Commun. 2006, 347: 406-412. 10.1016/j.bbrc.2006.06.092.PubMedCrossRef

31.

Matsumoto G, Stojanovic A, Holmberg CI, Kim S, Morimoto RI: Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J Cell Biol. 2005, 171: 75-85. 10.1083/jcb.200504050.PubMedPubMedCentralCrossRef

32.

Witan H, Gorlovoy P, Kaya AM, Koziollek-Drechsler I, Neumann H, Behl C, Clement AM: Wild-type Cu/Zn superoxide dismutase (SOD1) does not facilitate, but impedes the formation of protein aggregates of amyotrophic lateral sclerosis causing mutant SOD1. Neurobiol Dis. 2009, 36: 331-342. 10.1016/j.nbd.2009.07.024.PubMedCrossRef

33.

Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, Lopes EC, Patch JD, Hill AF, Cheema SS: Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci. 2005, 25: 108-117. 10.1523/JNEUROSCI.4253-04.2005.PubMedCrossRef

34.

Urushitani M, Ezzi SA, Matsuo A, Tooyama I, Julien JP: The endoplasmic reticulum-Golgi pathway is a target for translocation and aggregation of mutant superoxide dismutase linked to ALS. FASEB J. 2008, 22: 2476-2487. 10.1096/fj.07-092783.PubMedCrossRef

35.

Prudencio M, Durazo A, Whitelegge JP, Borchelt DR: An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum Mol Genet. 2010, 19: 4774-4789. 10.1093/hmg/ddq408.PubMedPubMedCentralCrossRef

36.

Symons MH, Mitchison TJ: Control of actin polymerization in live and permeabilized fibroblasts. J Cell Biol. 1991, 114: 503-513. 10.1083/jcb.114.3.503.PubMedCrossRef

37.

Callahan J, Kopeckov P, Kopecek J: Intracellular trafficking and subcellular distribution of a large array of HPMA copolymers. Biomacromolecules. 2009, 10: 1704-1714. 10.1021/bm801514x.PubMedPubMedCentralCrossRef

38.

Crapo JD, Oury T, Rabouille C, Slot JW, Chang L-Y: Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA. 1992, 89: 10405-10409. 10.1073/pnas.89.21.10405.PubMedPubMedCentralCrossRef

39.

Okamoto Y, Shirakashi Y, Ihara M, Urushitani M, Oono M, Kawamoto Y, Yamashita H, Shimohama S, Kato S, Hirano A, et al: Colocalization of 14-3-3 proteins with SOD1 in Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis cases and the animal model. PLoS ONE. 2011, 6: e20427-10.1371/journal.pone.0020427.PubMedPubMedCentralCrossRef

40.

Zetterstrom P, Stewart HG, Bergemalm D, Jonsson PA, Graffmo KS, Andersen PM, Brannstrom T, Oliveberg M, Marklund SL: Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc Natl Acad Sci USA. 2007, 104: 14157-14162. 10.1073/pnas.0700477104.PubMedPubMedCentralCrossRef

41.

Karumbayaram S, Kelly TK, Paucar AA, Roe AJ, Umbach JA, Charles A, Goldman SA, Kornblum HI, Wiedau-Pazos M: Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS. Dis Model Mech. 2009, 2: 189-195. 10.1242/dmm.002113.PubMedPubMedCentralCrossRef

42.

Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR: Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis. 2002, 10: 128-138. 10.1006/nbdi.2002.0498.PubMedCrossRef

43.

Liu HN, Sanelli T, Horne P, Pioro EP, Strong MJ, Rogaeva E, Bilbao J, Zinman L, Robertson J: Lack of evidence of monomer/misfolded superoxide dismutase-1 in sporadic amyotrophic lateral sclerosis. Ann Neurol. 2009, 66: 75-80. 10.1002/ana.21704.PubMedCrossRef

44.

Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, Hultdin M, Jacobsson J, Rosquist R, Marklund SL, Brannstrom T: Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE. 2010, 5: e11552-10.1371/journal.pone.0011552.PubMedPubMedCentralCrossRef

45.

Cashman NR, Durham HD, Blusztajn JK, Oda K, Tabira T, Shaw IT, Dahrouge S, Antel JP: Neuroblastoma × spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dynamics. 1992, 194: 209-221. 10.1002/aja.1001940306.CrossRef

46.

Niwa J, Yamada S, Ishigaki S, Sone J, Takahashi M, Katsuno M, Tanaka F, Doyu M, Sobue G: Disulfide bond mediates aggregation, toxicity, and ubiquitylation of familial amyotrophic lateral sclerosis-linked mutant SOD1. J Biol Chem. 2007, 282: 28087-28095. 10.1074/jbc.M704465200.PubMedCrossRef

47.

Witan H, Kern A, Koziollek-Drechsler I, Wade R, Behl C, Clement AM: Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation. Hum Mol Genet. 2008, 17: 1373-1385. 10.1093/hmg/ddn025.PubMedCrossRef

48.

Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, Rutkowski DT, Kaufman RJ, Ruse CI, Yates JR, et al: Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci USA. 2009, 106: 1392-1397. 10.1073/pnas.0813045106.PubMedPubMedCentralCrossRef

49.

Chen T, Benmohamed R, Arvanites AC, Ralay RH, Morimoto RI, Ferrante RJ, Watterson DM, Kirsch DR, Silverman RB: Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis. Bioorg Med Chem. 2011, 19: 613-622. 10.1016/j.bmc.2010.10.052.PubMedPubMedCentralCrossRef

50.

Ilieva H, Polymenidou M, Cleveland DW: Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009, 187: 761-772. 10.1083/jcb.200908164.PubMedPubMedCentralCrossRef

51.

Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, et al: Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science. 2003, 302: 113-117. 10.1126/science.1086071.PubMedCrossRef

52.

Wang J, Xu G, Slunt HH, Gonzales V, Coonfield M, Fromholt D, Copeland NG, Jenkins NA, Borchelt DR: Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA. Neurobiol Dis. 2005, 20: 943-952. 10.1016/j.nbd.2005.06.005.PubMedCrossRef

53.

Wang J, Xu G, Li H, Gonzales V, Fromholt D, Karch C, Copeland NG, Jenkins NA, Borchelt DR: Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: {alpha}B-crystallin modulates aggregation. Hum Mol Genet. 2005, 14: 2335-2347. 10.1093/hmg/ddi236.PubMedCrossRef

54.

Wang J, Xu G, Borchelt DR: High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol Dis. 2002, 9: 139-148. 10.1006/nbdi.2001.0471.PubMedCrossRef

55.

Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW: Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA. 1995, 92: 954-958. 10.1073/pnas.92.4.954.PubMedPubMedCentralCrossRef

56.

Borchelt DR, Wong PC, Becher MW, Pardo CA, Lee MK, Xu ZS, Thinakaran G, Jenkins NA, Copeland NG, Sisodia SS, et al: Axonal transport of mutant superoxide dismutase 1 and focal axonal abnormalities in the proximal axons of transgenic mice. Neurobiol Dis. 1998, 5: 27-35. 10.1006/nbdi.1998.0178.PubMedCrossRef

Title: Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states
Authors: Mercedes Prudencio
David R Borchelt
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Molecular Neurodegeneration / Issue 1/2011
Electronic ISSN: 1750-1326
DOI: https://doi.org/10.1186/1750-1326-6-77

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Flipping the switches: CD40 and CD45 modulation of microglial activation states in HIV associated dementia (HAD)

Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity

Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death

A glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo

Dantrolene is neuroprotective in Huntington's disease transgenic mouse model

Cu, Zn-superoxide dismutase 1 (SOD1) is a novel target of Puromycin-sensitive aminopeptidase (PSA/NPEPPS): PSA/NPEPPS is a possible modifier of amyotrophic lateral sclerosis